...
首页> 外文期刊>Journal of biomedicine & biotechnology >Cytokines and Growth Factors Stimulate Hyaluronan Production: Role of Hyaluronan in Epithelial to Mesenchymal-Like Transition in Non-Small Cell Lung Cancer
【24h】

Cytokines and Growth Factors Stimulate Hyaluronan Production: Role of Hyaluronan in Epithelial to Mesenchymal-Like Transition in Non-Small Cell Lung Cancer

机译:细胞因子和生长因子刺激透明质酸的产生:透明质酸在非小细胞肺癌上皮细胞向间充质样转变中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, we investigated the role of hyaluronan (HA) in non-small cell lung cancer (NSCLC) since close association between HA level and malignancy has been reported. HA is an abundant extracellular matrix component and its synthesis is regulated by growth factors and cytokines that include epidermal growth factor (EGF) and interleukin-1beta (IL-1beta). We showed that treatment with recombinant EGF and IL-1beta, alone or in combination with TGF-beta, was able to stimulate HA production in lung adenocarcinoma cell line A549. TGF-beta/IL-1beta treatment induced epithelial to mesenchymal-like phenotype transition (EMT), changing cell morphology and expression of vimentin and E-cadherin. We also overexpressed hyaluronan synthase-3 (HAS3) in epithelial lung adenocarcinoma cell line H358, resulting in induced HA expression, EMT phenotype, enhanced MMP9 and MMP2 activities and increased invasion. Furthermore, adding exogenous HA to A549 cells and inducing HA H358 cells resulted in increased resistance to epidermal growth factor receptor (EGFR) inhibitor, Iressa. Together, these results suggest that elevated HA production is able to induce EMT and increase resistance to Iressa in NSCLC. Therefore, regulation of HA level in NSCLC may be a new target for therapeutic intervention.
机译:在这项研究中,我们已经研究了透明质酸(HA)在非小细胞肺癌(NSCLC)中的作用,因为已经报道了HA水平与恶性肿瘤之间的紧密联系。 HA是一种丰富的细胞外基质成分,其合成受生长因子和细胞因子(包括表皮生长因子(EGF)和白介素1beta(IL-1beta))调控。我们显示,单独使用重组EGF和IL-1beta或与TGF-beta联合使用,能够刺激肺腺癌细胞A549中HA的产生。 TGF-β/IL-1β处理可诱导上皮向间充质样表型转变(EMT),改变细胞形态以及波形蛋白和E-钙粘蛋白的表达。我们还在上皮肺腺癌细胞系H358中过表达透明质酸合酶3(HAS3),导致诱导的HA表达,EMT表型,增强的MMP9和MMP2活性以及增加的侵袭。此外,向A549细胞添加外源HA并诱导HA H358细胞导致对表皮生长因子受体(EGFR)抑制剂易瑞沙(Ireessa)的抵抗力增强。总之,这些结果表明,HA生产的增加能够诱导EMT并增加NSCLC中对易瑞沙的抗药性。因此,调节NSCLC中HA水平可能是治疗干预的新目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号